Chongqing Taiji Industry (Group) Co Ltd
600129
Company Profile
Business description
Chongqing Taiji Industry (Group) Co Ltd is a China-based company engaged in the production and sales of Chinese and Western medicines. It is also engaged in the cultivation of medicinal herbs. Its products mainly include capsules, syrup, oral liquid, lyophilized series, tablets, infusion series, and injections. The company mainly conducts its business in domestic and overseas markets.
Contact
No. 18, Hengshan East Road
Yubei District
Chongqing401123
CHNT: +86 2372800072
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2026
Employees
10,864
Stocks News & Analysis
stocks
Beaten down real estate share receives legal blow
Real estate share remains cheap despite losing airport legal battle.
stocks
OpenAI joins the mega-AI lab IPO race, but timing is uncertain
The ChatGPT maker joined Anthropic in filing a confidential S-1 with the SEC, teeing up a future IPO.
stocks
What happens if Tesla and SpaceX merge?
We see a solid business case for a merger, but not without hurdles, including Tesla shareholders’ concern about SpaceX’s valuation.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,006.10 | 29.10 | 0.32% |
| CAC 40 | 8,350.87 | 150.08 | 1.83% |
| DAX 40 | 24,612.56 | 402.85 | 1.66% |
| Dow JONES (US) | 51,152.21 | 303.46 | 0.60% |
| FTSE 100 | 10,471.72 | 167.84 | 1.63% |
| HKSE | 24,718.10 | 468.81 | 1.93% |
| NASDAQ | 25,782.57 | 27.09 | -0.10% |
| Nikkei 225 | 66,020.04 | 1,802.77 | 2.81% |
| NZX 50 Index | 13,393.87 | 191.71 | 1.45% |
| S&P 500 | 7,410.74 | 16.44 | 0.22% |
| S&P/ASX 200 | 8,804.00 | 30.50 | 0.35% |
| SSE Composite Index | 4,031.51 | 44.50 | 1.12% |